ARCHIVES

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Kentucky Okays Cancer Commission, $1 Million Budget

April 21, 1978

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

November 5, 2004

BRMP Proposals for Thymosins Development

November 30, 1979

Another Potti Paper Retracted

September 16, 2011

NCI Plans Conference On DES Late Effects, Reproductive Cancers

November 29, 1991

In Brief: NIH Appeals Board Restores Nassau CCOP Funding, PI Says It Is Now Meeting Patient Accrual Goal

February 22, 1985